Literature DB >> 31602892

[Correlation between lipid-lowering efficacy and components of Pericarpium Citri Reticulatae].

Jing-Jing Yu1, Jie Su1, Mei-Qiu Yan1, Zhao-Huan Lou1, Gui-Yuan Lyu1.   

Abstract

Based on pharmacodynamics-component correlation analysis,the best effective part of hyperlipidemia of Pericarpium Citri Reticulatae( PCR) was screened out to confirm the possible constituents with the lipid regulating effect,in order to provide a basis for the development of new drugs. Hyperlipidemia rats induced by fat emulsion were used to screen out the best hypolipidemic parts of PCR with TC,LDL-c as the index. HPLC-ESI-MS were used to analyze common constituents of the different solvent extracts from PCR. The constituents were classified and identified based on the retention time,m/z and UV spectra. And the HPLC-DAD were used to determine the contents of flavonoids( narirutin,hesperidin,didymin,nobiletin,tangeretin,3,5,6,7,8,3',4'-heptemthoxyflavone).Correlation analysis was conducted on the constituents and efficacy with the method of SPSS ANOVA bivariate correlation. Five extracts could significantly decrease the content of TC,LDL-c of hyperlipemia rats induced by fat emulsion,and the best effective part were95% ethanol and ethyl acetate. There were 19 common peaks in five different solvent extracts from PCR,and 17 flavonoids were identified and classified,including 10 polymethoxyflavonoids and 7 other flavonoids. According to the raw material quantity,the order of content of flavonones arranged from high to low: n-butyl alcohol part> 95% ethanol part> water part> ethyl acetate part> petroleum ether part; and the order of PMFs arranged from high to low: n-butyl alcohol part≈95% ethanol part≈ethyl acetate part > petroleum ether part > water part. The decreased percentage of TC,LDL-c was positively correlated with 10 common PMFs constituents,which suggested that PMFs may be the effective components for reducing blood lipid.

Entities:  

Keywords:  Pearson correlation analysis; Pericarpium Citri Reticultae; flavonones; hyperlipidemia; polymethoxyflavonoids(PMFs)

Mesh:

Substances:

Year:  2019        PMID: 31602892     DOI: 10.19540/j.cnki.cjcmm.20190523.304

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Extract of Acalypha australis L. inhibits lipid accumulation and ameliorates HFD-induced obesity in mice through regulating adipose differentiation by decreasing PPARγ and CEBP/α expression.

Authors:  Lang You; Fengxia Li; Yan Sun; Liang Luo; Jian Qin; Tao Wang; Yuchen Liu; Ruogu Lai; Ruohan Li; Xiaoran Guo; Qiuyan Mai; Yihang Pan; Jianrong Xu; Ningning Li
Journal:  Food Nutr Res       Date:  2021-03-01       Impact factor: 3.894

2.  A Novel Herbal Medicine for Dyslipidemia: Assessments in Experimental Models.

Authors:  Pham Ba Tuyen; Truong Thi Huyen; Dinh Thi Thu Hang; Pham Thi Van Anh
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-22       Impact factor: 2.629

Review 3.  Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects.

Authors:  Ying Hu; Xingjuan Chen; Mu Hu; Dongwei Zhang; Shuo Yuan; Ping Li; Ling Feng
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.